The pharmaceutical world is seeing a significant shift in blood sugar management with the introduction of GLP-1 skin applications. These systems offer a potentially more comfortable alternative to shots of GLP-1 receptor agonists, lessening the requirement of daily needle pokes. The technology releases the compound directly through the skin, possib